Back
NeoGenomics Vs. Halozyme Therapeutics Industry Stock Comparison
Buy
57
NEO
NeoGenomics
Last Price:
15.19
Seasonality Move:
2.36%
Buy
74
HALO
Halozyme Therapeutics
Last Price:
42.31
Seasonality Move:
7.93%
Buy
57
NeoGenomics (NEO)
is a Buy
Is NeoGenomics a Buy, Sell or Hold?
- The current NeoGenomics [NEO] share price is $15.58. The Score for NEO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- NEO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
74
Halozyme Therapeutics (HALO)
is a Buy
Is Halozyme Therapeutics a Buy, Sell or Hold?
- The current Halozyme Therapeutics [HALO] share price is $41.27. The Score for HALO is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- HALO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NEO Stock Price Chart
What is NeoGenomics's stock price today?
-
The NeoGenomics share price today is $15.58
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NEO is experiencing slight buying pressure.
HALO Stock Price Chart
What is Halozyme Therapeutics's stock price today?
-
The Halozyme Therapeutics share price today is $41.27
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HALO is experiencing slight buying pressure.
NEO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 59.61 | Buy |
| Chaikin Money Flow: | 132068 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.77 - 15.05) | Buy |
| Bollinger Bands (100): | (14.02 - 17.26) | Sell |
HALO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 64.38 | Buy |
| Chaikin Money Flow: | 11589 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.34 - 40.2) | Buy |
| Bollinger Bands (100): | (35.56 - 40.6) | Buy |
NEO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.8 | Buy |
| 20-day SMA: | 14.27 | Buy |
| 50-day SMA: | 14.91 | Buy |
| 200-day SMA: | 15.33 | Buy |
| 8-day EMA: | 14.91 | Buy |
| 20-day EMA: | 14.62 | Buy |
| 50-day EMA: | 14.84 | Buy |
| 200-day EMA: | 15.34 | Buy |
HALO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.58 | Buy |
| 20-day SMA: | 39.03 | Buy |
| 50-day SMA: | 40.03 | Buy |
| 200-day SMA: | 38.79 | Buy |
| 8-day EMA: | 39.94 | Buy |
| 20-day EMA: | 39.51 | Buy |
| 50-day EMA: | 39.25 | Buy |
| 200-day EMA: | 38.88 | Buy |
NeoGenomics Earnings Growth & NEO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.03 per share, an increase this year of $0.20 per share, and an increase next year of $0.14 per share.
Halozyme Therapeutics Earnings Growth & HALO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.81 per share, and an increase next year of $0.87 per share.
NeoGenomics Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Halozyme Therapeutics Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||